The weekly litigation news digest is live. Subscribe now

IP Verse

Animal Models And Therapeutic Molecules - EP3622813

The patent EP3622813 was granted to Kymab on Jun 19, 2024. The application was filed on Jul 7, 2010 under application number EP19207050A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3622813

KYMAB
Application Number
EP19207050A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
May 17, 2024
Publication Date
Jun 19, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
REGENERON PHARMACEUTICALSFeb 18, 2021J A KEMPWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5859307
DESCRIPTIONWO0104288
DESCRIPTIONWO2007117410
DESCRIPTIONWO2010039900
DESCRIPTIONWO9929837
OPPOSITIONUS2012204278
OPPOSITIONUS7205148
OPPOSITIONWO02066630
OPPOSITIONWO2007117410
OPPOSITIONWO2009013620
OPPOSITIONWO2009076464
OPPOSITIONWO2010039900
OTHEREP2517556
SEARCHUS2006015957
SEARCHWO02066630
SEARCHWO2007117410

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents